In March 2025, the company introduced new strategies for the immediate-to-purchaser offering of its Wegovy weight loss drug. The company proven a fresh pharmacy, termed NovoCare, which might demand shoppers $499 a month for entry to the drug, a lot less than 50 % the cost of the drug by way of other pharmaceutical distribution networks.[fifty three